$LMND News

Morgan Stanley Maintains Overweight on Lemonade, Lowers Price Target to $75

Piper Sandler Maintains Neutral on Lemonade, Lowers Price Target to $62

Citizens Maintains Market Outperform on Lemonade, Lowers Price Target to $80

Truist Securities Maintains Buy on Lemonade, Lowers Price Target to $70

Lemonade, Inc. (LMND) Q1 2026 Earnings Call Transcript

Lemonade, Inc. 2026 Q1 - Results - Earnings Call Presentation

Lemonade: 'Buy' The Dip As IFP Soars

What's Going On With Lemonade Stock Wednesday?

Lemonade (NYSE:LMND) Q1 2026 Earnings Beat Sends Shares Up 6%

Lemonade shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 sales guidance above estimates.

Lemonade Raises FY2026 Sales Guidance from $1.187B-$1.192B to $1.197B-$1.203B vs $1.195B Est

Lemonade Sees Q2 Sales $287.000M-$290.000M vs $288.111M Est

Lemonade Q1 EPS $(0.47) Beats $(0.58) Estimate, Sales $258.000M Beat $251.501M Estimate

Lemonade: From Growth Story To Margin Expansion Machine

Morgan Stanley Upgrades Lemonade (LMND)

Lemonade shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target on the stock from $80 to $85.

Morgan Stanley Upgrades Lemonade to Overweight, Raises Price Target to $85

Should You Buy Lemonade (LMND) While It's Below $65?

Assessing Lemonade (LMND) Valuation After Strong Returns And Recent Share Price Pullback

Is Lemonade, Inc. (LMND) A Good Stock To Buy Now?